Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$5.5 - $9.19 $2,750 - $4,595
-500 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$7.67 - $44.59 $1,326 - $7,714
173 Added 52.91%
500 $4,000
Q4 2021

Jan 14, 2022

SELL
$7.67 - $44.59 $1,326 - $7,714
-173 Reduced 34.6%
327 $4,000
Q2 2021

Jul 23, 2021

BUY
$19.22 - $59.08 $9,610 - $29,540
500 New
500 $11,000

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $281M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Edge Wealth Management LLC Portfolio

Follow Edge Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Wealth Management LLC with notifications on news.